GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-53.21 | ₹10.53 | ₹33.37 | ₹34.38 | ₹27.50 |
What is the latest Earnings Per Share (EPS) of GLENMARK PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹-53.21 |
| Mar2024 | ₹10.53 |
| Mar2023 | ₹33.37 |
| Mar2022 | ₹34.38 |
| Mar2021 | ₹27.50 |
How is Earnings Per Share (EPS) of GLENMARK PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹-53.21 | Negative | |
| Mar2024 | ₹10.53 | -68.44 | |
| Mar2023 | ₹33.37 | -2.94 | |
| Mar2022 | ₹34.38 | 25.02 | |
| Mar2021 | ₹27.50 | - | |
Compare Earnings Per Share (EPS) of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,202.1 Cr | -4.1% | 2.6% | 40.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | -1.5% | 1.6% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | -2% | -4.3% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | -0.8% | 0.5% | 32% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | -2.7% | -1.6% | 6.9% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | -3.9% | -9.1% | -18.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -4.1% |
2.6% |
40.4% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses